Background: Many patients who have surgery for acute cholecystitis receive postoperative antibiotic prophylaxis, with the intent to reduce infectious complications. There is, however, no evidence that extending antibiotics beyond a single perioperative dose is advantageous. This study aimed to determine the effect of extended antibiotic prophylaxis on infectious complications in patients with mild acute cholecystitis undergoing cholecystectomy. 
Introduction
Acute calculous cholecystitis is a frequent cause of emergency admission to surgical wards. Approximately 120 000 cholecystectomies are performed for acute cholecystitis in North America each year 1 . Emergency cholecystectomy is considered a low-risk procedure, although the complication rate ranges from 15 per cent for early cholecystectomy to 30 per cent for delayed cholecystectomy 2 . The most common complication is a surgical-site infection, which occurs in approximately 10 per cent of patients who have surgery for mild to moderate cholecystitis 3 .
In current practice, many patients with acute cholecystitis receive perioperative antibiotic prophylaxis, often continued for several postoperative days to reduce infectious complications. Guidelines recommend antimicrobial therapy in different doses and durations, varying from 24 h to 7 days, depending on the severity of cholecystitis 4 -6 . These guidelines are, however, based on low-quality evidence 5 . There is a lack of randomized trials demonstrating any beneficial effect of extended postoperative antibiotic treatment after cholecystectomy for acute cholecystitis. Thus the use of perioperative antibiotics is variable among physicians, hospitals and countries. Disadvantages of extended postoperative antibiotic prophylaxis include prolongation of hospital stay with increased medical costs, and potentially increased bacterial resistance.
The aim of the present study was to determine the effect of extended postoperative antibiotic prophylaxis on postoperative infectious complications in patients undergoing emergency cholecystectomy for mild acute calculous cholecystitis. The hypothesis was that the absence of extended antibiotic treatment after cholecystectomy would not lead to an increase in infectious complications.
Methods
This randomized controlled, open, parallel-group, non-inferiority trial was designed following the CON-SORT guidelines (http://www.consort-statement.org/). The study protocol was approved by the institutional review board on 4 April 2012. Secondary approval of the protocol was obtained from all local ethics committees of the participating hospitals. Patients were recruited at six major teaching hospitals in the Netherlands between April 2012 and October 2014. The trial was registered in the Dutch Trial Register (www.trialregister.nl) with identification number NTR3089.
Study participants and eligibility criteria
Adult patients suffering from mild acute calculous cholecystitis, with an Acute Physiology And Chronic Health Evaluation (APACHE) II score of 6 or lower, were considered eligible for the trial 7 . Acute cholecystitis was defined according to the Tokyo guidelines 8 . Specific eligibility criteria are shown in Table 1 . Written informed consent was obtained from all included patients before randomization.
Randomization
Randomization was performed by the study coordinator or primary investigator using an online generator (ALEA 2.2; Academic Medical Centre, Amsterdam, The Netherlands; https://nl.tenalea.net/amc/ALEA/). Permutedblock randomization with varying block sizes was used. The sequence of the different blocks was predetermined by an independent programmer and concealed from all investigators. The blocks were generated separately within the different study sites, stratified by hospital. Neither the patients nor the investigators were blinded to treatment allocation. Laparoscopic cholecystectomy had to be performed within 24 h after randomization.
Procedures and intervention
All patients presenting with suspected acute calculous cholecystitis at the emergency department underwent standard evaluation, including laboratory measurements and abdominal ultrasound imaging. Once included, patients received a single prophylactic dose of antibiotics 15-30 min before surgery (cefazolin 2000 mg intravenously).
Laparoscopic cholecystectomy was performed by the four-trocar technique, with transection of the cystic duct and artery after reaching the critical view of safety as described by Strasberg 1 . Patients randomized to the extended antibiotic group were admitted for 3 days after surgery to receive intravenous cefuroxime 750 mg and metronidazole 500 mg three times daily. Patients randomized to the standard prophylaxis group received no Extended versus single-dose perioperative antibiotic prophylaxis for acute calculous cholecystitis e153 antibiotic treatment after surgery, and were discharged home according to clinical condition.
Data collection
Baseline characteristics (sex, age, BMI, co-morbidity, APACHE II score, laboratory findings, duration of symptoms) were documented on admission. Operative details (duration of surgery, difficulty, intraoperative events) and clinical data (vital signs, laboratory data, complications) were collected by local physicians using case report forms. The study coordinator verified all completed forms in accordance with on-site source data. Discrepancies detected by the study coordinator were resolved through consensus by two investigators not involved in patient care. Follow-up took place in outpatients 1 month after discharge.
Outcomes
The primary endpoint of the trial was a composite of all infectious complications within 30 days after cholecystectomy. Definitions are provided in Table 2 . The secondary endpoints included all individual components of the primary endpoint, all other complications and total duration of hospital stay. Complications were assessed according to Dindo-Clavien classification grades 9 . A data safety monitoring committee of three independent clinicians assessed all serious adverse events after inclusion of every 30 patients in an unblinded fashion.
Statistical analysis
Owing to a lack of published data, the sample size calculation was derived from data from a retrospective cohort of 279 patients who underwent laparoscopic cholecystectomy for acute cholecystitis in St Antonius Hospital between 2002 and 2010 (unpublished data). An overall infectious complication rate of 12 per cent was found, which was used as the reference. Patients who had prolonged antibiotic treatment had a complication rate of 17 per cent versus 7 per cent in patients not receiving prolonged antibiotic treatment. Although higher infectious complication rates were encountered in patients who had extended antibiotic treatment, this finding seemed to be (partly) due to selection bias. The difference between the lowest encountered rate (7 per cent) and the overall infectious complication rate (12 per cent) was 5 per cent, which was defined as the acceptable difference (non-inferiority margin). The hypothesis of this study was that a single dose of antibiotic prophylaxis (standard prophylaxis) would not be inferior to extended prophylaxis for development of infectious complications within 4 weeks after cholecystectomy. To demonstrate non-inferiority, a total of 156 patients (78 in each group) had to be randomized, for which infection rates of 7 per cent in the single-dose group and 14 per cent in the extended group were assumed, with 80 per cent power and a one-sided 5 per cent α level.
Patients were analysed according to the intention-totreat approach. Dichotomous data and counts are presented as frequencies. Continuous data are presented median (range). The χ 2 test or Fisher's exact test was used for analysis of nominal data, and the Mann-Whitney U test for continuous data. Non-inferiority was determined by computing the 95 per cent c.i. for the difference in incidence of the primary endpoint. Two-tailed P < 0⋅050 was considered statistically significant. Statistical analysis was done using SPSS ® version 21 (IBM, Armonk, New York, USA).
Results
Between April 2012 and October 2014, a total of 156 patients were randomized, 81 in the extended antibiotic group and 75 in the standard prophylaxis group (Fig. 1) . Because treatment of acute cholecystitis was often performed in an acute setting outside regular working hours, data on patients who were eligible, but not recruited, were incomplete. In the initiating hospital, however, this information was well documented: 223 patients were assessed for eligibility during the study interval, 134 of whom were eligible for inclusion. Eighty patients (59⋅7 per cent) were included in the trial whereas 54 (40⋅3 per cent) were not asked or declined participation. The characteristics of the latter patients were similar to those of included patients (data not shown). Six patients were excluded after randomization: one patient revoked informed consent, one refused hospital admission, one used antibiotics before randomization, two did not undergo a cholecystectomy and one patient was double-randomized. A total of 150 patients remained for data analysis: 77 in the extended antibiotic group and 73 in the standard prophylaxis group.
Adherence to study protocol
Laparoscopic cholecystectomy was performed within 24 h after randomization in all patients. In the extended antibiotic group, the study protocol was adhered to accurately in 66 of 77 patients (86 per cent); four patients did not receive extended postoperative antibiotic prophylaxis, three received antibiotics for 1 day, and four patients received antibiotics for 2 days. In the standard prophylaxis group, the protocol was adhered to accurately in 71 of 73 patients (97 per cent); in two patients the surgeon felt that extended antibiotic treatment was indicated because a necrotic gallbladder was encountered during surgery.
Baseline characteristics
There were no differences in baseline characteristics between the two groups ( Table 3) . Four (2⋅7 per cent) of the 150 laparoscopic procedures were converted to open cholecystectomy: one (1 per cent) in the extended antibiotic group because of adhesions and three (4 per cent) in the standard prophylaxis group owing to lack of exposure. Escherichia coli was isolated most frequently, followed by Klebsiella pneumoniae. None of the observed differences reached statistical significance.
Primary outcome
In the intention-to-treat analysis, three of 77 patients (4 per cent) in the extended antibiotic group and three of 73 (4 per cent) in the standard prophylaxis group developed postoperative infectious complications (absolute difference 0⋅2 (95 per cent c.i. − 8⋅2 to 8⋅9) per cent) ( Table 4) . Based on this result, non-inferiority of single-dose postoperative antibiotic prophylaxis compared with extended prophylaxis for development of infectious complications cannot be proven, because the non-inferiority margin of 5 per cent lies within the confidence interval. In per-protocol analysis, the postoperative infectious complication rate was 4 per cent (3 of 75) in both groups.
Secondary outcomes
The rate of infectious and non-infectious complications combined, was 12 of 77 (16 per cent) in the extended antibiotic group and eight of 73 (11 per cent) in the standard prophylaxis group (P = 0⋅405) ( Table 4 ). All but two complications were Dindo-Clavien grade II or lower, and resolved either spontaneously or with non-invasive therapy. The remaining two complications were graded Dindo-Clavien IIIB, and included cystic duct leakage requiring endoscopic retrograde cholangiopancreatography (ERCP) on the fourth postoperative day, and choledocholithiasis requiring ERCP and readmission. Empyema was present in ten patients (13 per cent) in the extended antibiotic group, none of whom developed an infectious complication, and seven (10 per cent) in the standard prophylaxis group, of whom one developed a urinary tract infection.
The median duration of hospital stay was 3 (range 1-4) days in the extended antibiotic group and 1 (1-5) days in the standard prophylaxis group (P < 0⋅001) ( Table 4 ). There were no deaths in either of the groups.
Discussion
The absence of extended antibiotic treatment did not lead to an increase in postoperative infectious complications in patients with mild acute cholecystitis undergoing cholecystectomy. The infectious complication rate was 4 per cent in both groups. Although non-inferiority of standard single-dose prophylaxis compared with extended prophylaxis cannot be proven, extended antibiotic prophylaxis seems clinically irrelevant considering the low overall infection rate.
According to the Tokyo guidelines 5 and the guidelines published by the Surgical Infection Society and the Infectious Diseases Society of America 6 , the selection and duration of antibiotic prophylaxis should be guided by the severity of cholecystitis and whether or not the source of infection is well controlled. In mild cases, postoperative treatment with cephalosporins is recommended, which can be discontinued within 24 h after surgery 5, 6 . Antibiotic treatment for 4-7 days is recommended if perforation, surgical emphysema or gallbladder necrosis is encountered during surgery, or in patients with moderate or severe acute cholecystitis. These guidelines, however, are based on low-quality evidence (which might contribute to the low adherence to these guidelines). Among clinicians, there is no consensus regarding the duration of perioperative antibiotics, and as a result the use of antibiotics is dependent mainly on the patient's clinical condition, perioperative findings and, most of all, the surgeon's preference.
The effectiveness of prophylactic antibiotics in elective cholecystectomy has been studied in several randomized trials 10 -14 , clearly demonstrating no reduction in the risk of surgical-site infections in low-risk patients. According to recent studies 3, 15 , the use of antibiotic prophylaxis is disputable even in urgent cholecystectomy. Regimbeau and colleagues 3 conducted a large randomized trial demonstrating no beneficial effect of postoperative treatment with amoxicillin plus clavulanic acid on the infectious complication rate in patients with mild or moderate acute cholecystitis undergoing emergency cholecystectomy. Also in 2014, Jaafar and co-workers 15 found no significant benefit of antibiotic prophylaxis on postoperative infectious complications in patients undergoing acute cholecystectomy, in a large retrospective nationwide study in Sweden. The present study corroborates these findings in low-risk patients with acute calculous cholecystitis.
Similarly, the use of antibiotics is disputable even in the conservative management of acute cholecystitis. A recent systematic review 16 demonstrated that there is little evidence on this subject, and the available evidence is of poor quality and has a high risk of bias. The review identified only one small study 17 that compared antibiotic treatment with a conservative strategy without antibiotics, showing that antibiotics did not improve the outcome of acute calculous cholecystitis.
The rationale for perioperative antibiotics is based on the results of either bile or gallbladder cultures from patients with acute cholecystitis. Positive cultures are reported in minority of the patients, ranging from 29 to 54 per cent 5,18 -24 . In the present study, intraoperative bile cultures were obtained in 51 patients, of which 39 per cent were positive. E. coli was found most frequently, followed by K. pneumoniae, which is in accordance with the results in previous studies 5,18 -25 . Cefuroxime is effective against these bacteria. Owing to the small number of bile cultures obtained, correlation between positive bile culture and infectious complications could not be performed. Nevertheless, none of the 20 patients with a positive bile culture developed an infection. Studies comparing postoperative outcome according to the presence or absence of bacteria have shown a significantly higher incidence of infectious and non-infectious postoperative complications in the group with bacteria in the bile 26, 27 .
The hypothesis of the present study was that a single dose of antibiotic prophylaxis would not be inferior to extended prophylaxis. The sample size calculations were based on an expected infectious complication rate of 12 per cent, according to findings in a retrospective cohort. The present study included only patients with mild acute cholecystitis and reported a postoperative infectious complication rate of only 4 per cent, much lower than expected. Consequently, non-inferiority could not be proven. In retrospect, a sample size of almost 600 patients would be needed to demonstrate non-inferiority. Considering the very low infection rate, it is questionable whether such a study is still necessary.
Extended intravenous antibiotic prophylaxis leads to prolongation of hospital stay. As acute cholecystectomy is a frequently performed operation, increasing the duration of hospital stay will have a large impact on healthcare costs. Oral antibiotics might be an alternative to shorten hospital stay; however, because intravenous antibiotics did not reduce infectious complications, this will most likely also be the case for oral antibiotics. In addition, bacterial resistance is a serious and growing issue in contemporary medicine. Thus, reducing needless use of antibiotics is of upmost importance.
